Literature DB >> 9421862

Drugs and sport. Research findings and limitations.

P M Clarkson1, H S Thompson.   

Abstract

Many types of drugs are used by athletes to improve performance. This paper reviews the literature on 3 categories of drugs: those that enhance performance as stimulants (amphetamines, ephedrine, and cocaine), those that are used to reduce tremor and heart rate (beta-blockers) and those involved in bodyweight gain or loss (anabolic-androgenic steroids, growth hormone, beta 2-agonists, and diuretics). Limitations of research on these drugs as they relate to performance enhancement are also discussed. The numerous studies that have assessed the effects of amphetamines on performance report equivocal results. This may be due to the large interindividual variability in the response to the drug and the small sample sizes used. Most studies, however, show that some individuals do improve exercise performance when taking amphetamines, which may be attributed to their role in masking fatigue. As a stimulant, ephedrine has not been found to improve performance in the few studies available. More recently, ephedrine has been purported to be effective as a fat burner and used by athletes to maintain or improve muscle mass. Although research on individuals with obesity supports the use of ephedrine for fat loss, no studies have been done on athletes. The few studies of cocaine and exercise suggest that little to no performance gains are incurred from cocaine use. Moreover, the sense of euphoria may provide the illusion of better performance when, in actuality, performance was not improved or was impaired. beta-Blockers have been found to reduce heart rate and tremor and to improve performance in sports that are not physiologically challenging but require accuracy (e.g. pistol shooting). However, there is evidence that some individuals may be high responders to beta-blockers to the extent that their heart rate response is so blunted as to impair performance. Although equivocal, several studies have reported that anabolic-androgenic steroids increase muscle size and strength. However, most studies are not well controlled and use insufficient drug doses. One recent well controlled study did find an increase in muscle mass and strength with supraphysiological doses, and the improvements were greater in participants who were also resistance training. There is little information available on the effects of growth hormone on muscle mass or performance in athletes, although data suggest that growth hormone administration does not increase muscle protein synthesis. beta 2-Agonists, such as clenbuterol and salbutamol, when administered orally appear to improve muscular strength due to their potential role in increasing muscle mass. However, studies have not been done using athletes. Diuretics results in a loss of body water and hence bodyweight that can be advantageous for sports with strict bodyweight classifications. There is insufficient evidence on possible performance decrements in the field that could result from dehydration induced by the diuretics. Overall, the most significant concern in studies of drug use is the large inter-individual variability in responses to a drug. Further studies are needed to understand why some individuals are more responsive than others and to assess whether the responses are consistent for a given individual. Most studies of drug effectiveness have not used athletes. The effectiveness of many drugs may be reduced in highly trained athletes because there is a lower margin for improvement.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9421862     DOI: 10.2165/00007256-199724060-00003

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  107 in total

Review 1.  Asthmatic drugs and competitive sport. An update.

Authors:  A R Morton; K D Fitch
Journal:  Sports Med       Date:  1992-10       Impact factor: 11.136

2.  Heat tolerance following diuretic induced dehydration.

Authors:  A D Claremont; D L Costill; W Fink; P Van Handel
Journal:  Med Sci Sports       Date:  1976

3.  Anabolic-Androgenic Steroid Use Among 1,010 College Men.

Authors:  H G Pope; D L Katz; R Champoux
Journal:  Phys Sportsmed       Date:  1988-07       Impact factor: 2.241

4.  Exercise Testing, Training, and Beta-Adrenergic Blockade.

Authors:  J H Wilmore
Journal:  Phys Sportsmed       Date:  1988-12       Impact factor: 2.241

5.  Anabolic steroid: effects on strength development.

Authors:  L C Johnson; J P O'Shea
Journal:  Science       Date:  1969-05-23       Impact factor: 47.728

Review 6.  The use of drugs in swimming.

Authors:  J C Puffer
Journal:  Clin Sports Med       Date:  1986-01       Impact factor: 2.182

Review 7.  Exercise performance and beta-blockade.

Authors:  P A Tesch
Journal:  Sports Med       Date:  1985 Nov-Dec       Impact factor: 11.136

8.  Lipid profile of body builders with and without self-administration of anabolic steroids.

Authors:  J Fröhlich; T Kullmer; A Urhausen; R Bergmann; W Kindermann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

Review 9.  The use and misuse of androgens.

Authors:  J D Wilson; J E Griffin
Journal:  Metabolism       Date:  1980-12       Impact factor: 8.694

Review 10.  Anabolic-androgenic steroids. Current issues.

Authors:  C E Yesalis; M S Bahrke
Journal:  Sports Med       Date:  1995-05       Impact factor: 11.136

View more
  19 in total

Review 1.  Athletes and doping: effects of drugs on the respiratory system.

Authors:  P N Dekhuijzen; H A Machiels; L M Heunks; H F van der Heijden; R H van Balkom
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

Review 2.  A conceptual framework for achieving performance enhancing drug compliance in sport.

Authors:  Robert J Donovan; Garry Egger; Vicki Kapernick; John Mendoza
Journal:  Sports Med       Date:  2002       Impact factor: 11.136

Review 3.  The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis.

Authors:  Amy B Cadwallader; Xavier de la Torre; Alessandra Tieri; Francesco Botrè
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 4.  Asthma and athletes: therapy to compete.

Authors:  John M Weiler; Christine Malloy
Journal:  Clin Rev Allergy Immunol       Date:  2005-10       Impact factor: 8.667

Review 5.  Banned drugs in sport. Does the International Olympic Committee (IOC) list need updating?

Authors:  D R Mottram
Journal:  Sports Med       Date:  1999-01       Impact factor: 11.136

Review 6.  Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.

Authors:  Faidon Magkos; Stavros A Kavouras
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

7.  No variation of physical performance and perceived exertion after adrenal gland stimulation by synthetic ACTH (Synacthen) in cyclists.

Authors:  Norbert Baume; Graeme Steel; Tony Edwards; Eric Thorstensen; Benjamin F Miller
Journal:  Eur J Appl Physiol       Date:  2008-06-27       Impact factor: 3.078

8.  Salbutamol exhibits androgenic activity in vitro.

Authors:  André O von Bueren; Risheng Ma; Margret Schlumpf; Walter Lichtensteiger
Journal:  Br J Sports Med       Date:  2007-05-17       Impact factor: 13.800

9.  Effects of dexamethasone on the expression of beta(1)-, beta (2)- and beta (3)-adrenoceptor mRNAs in skeletal and left ventricle muscles in rats.

Authors:  Fuuun Kawano; Jun Tanihata; Shogo Sato; Sachiko Nomura; Akira Shiraishi; Kaoru Tachiyashiki; Kazuhiko Imaizumi
Journal:  J Physiol Sci       Date:  2009-07-08       Impact factor: 2.781

10.  Changes in feeding and locomotion induced by amphetamine analogs in rats.

Authors:  Paul J Wellman; Kristina W Davis; P Shane Clifford; Richard B Rothman; Bruce E Blough
Journal:  Drug Alcohol Depend       Date:  2008-12-04       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.